Insider Transactions in Q4 2025 at Novo Cure LTD (NVCR)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 04
2025
|
Mukund Paravasthu Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,949
-3.54%
|
$35,388
$12.23 P/Share
|
|
Nov 04
2025
|
Christoph Brackmann Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,033
-4.98%
|
$84,396
$12.23 P/Share
|
|
Nov 01
2025
|
Mukund Paravasthu Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
168
-0.2%
|
$2,016
$12.81 P/Share
|
|
Nov 01
2025
|
Frank X Leonard EVP, Pres., Novocure Oncology |
SELL
Payment of exercise price or tax liability
|
Direct |
966
-0.28%
|
$11,592
$12.81 P/Share
|
|
Oct 31
2025
|
Michal Nath Puri Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
752
-0.46%
|
$9,024
$12.82 P/Share
|